Tag: FDA Advocacy

Your Generic Drug Label Doesn’t Tell You EVERYTHING

Last week we attended a public meeting at the Food and Drug Administration (FDA) where we testified in front of supporters and opponents on behalf of the FDA’s proposed rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products.

Read More